27753194|t|Assessment of transient elastography in Japanese patients with non-alcoholic fatty liver disease
27753194|a|Transient elastography (TE) is a non-invasive method for predicting liver fibrosis. However, there are limited data regarding the performance of TE in Japanese patients with non-alcoholic fatty liver disease (NAFLD). We aimed to evaluate the association between liver stiffness measurement (LSM) by TE and liver fibrosis stage, and define a cut-off value for predicting liver fibrosis. A total of 171 Japanese patients with biopsy - proven NAFLD underwent LSM using TE with FibroScan. The area under the receiver operating characteristic curve of LSM and other non-invasive markers of liver fibrosis were compared to determine the most accurate method of predicting liver fibrosis. Liver stiffness measurement significantly correlated with fibrosis stage (P < 0.001). The areas under the receiver operating characteristic curve of LSM for fibrosis stage ≥1 and ≥3 was 0.85 and 0.91, respectively and were higher than those of the aspartate aminotransferase / alanine aminotransferase ratio, aspartate aminotransferase to platelet ratio index, fibrosis-4 index, and NAFLD fibrosis score. The best cut-off values of LSM fibrosis stage ≥1 and ≥3 were 7.2 kPa (sensitivity 78.5%, specificity 78.3%) and 10.0 kPa (sensitivity 89.5%, specificity 87.6%), respectively. The combination of LSM (≥10 kPa) and type IV collagen 7 s (≥6.0 ng/mL) had a specificity of 97.6% for advanced fibrosis. The LSM in patients with high alanine aminotransferase levels or high body mass index was associated with false positive results regarding advanced fibrosis. In NAFLD patients, TE has excellent utility for the assessment of liver fibrosis, particularly for advanced stage cases. The cut-off value of LSM by TE for predicting liver fibrosis stage ≥3 is 10.0 kPa in Japanese NAFLD patients.
27753194	14	36	transient elastography	T058	UMLS:C2748260
27753194	40	48	Japanese	T098	UMLS:C1556094
27753194	63	96	non-alcoholic fatty liver disease	T038	UMLS:C0400966
27753194	97	119	Transient elastography	T058	UMLS:C2748260
27753194	121	123	TE	T058	UMLS:C2748260
27753194	143	149	method	T058	UMLS:C0871511
27753194	165	179	liver fibrosis	T038	UMLS:C0239946
27753194	242	244	TE	T058	UMLS:C2748260
27753194	248	256	Japanese	T098	UMLS:C1556094
27753194	271	304	non-alcoholic fatty liver disease	T038	UMLS:C0400966
27753194	306	311	NAFLD	T038	UMLS:C0400966
27753194	396	398	TE	T058	UMLS:C2748260
27753194	403	423	liver fibrosis stage	T033	UMLS:C1954435
27753194	467	481	liver fibrosis	T038	UMLS:C0239946
27753194	498	506	Japanese	T098	UMLS:C1556094
27753194	521	527	biopsy	T058	UMLS:C0005558
27753194	537	542	NAFLD	T038	UMLS:C0400966
27753194	563	565	TE	T058	UMLS:C2748260
27753194	571	580	FibroScan	T058	UMLS:C2748260
27753194	586	590	area	T082	UMLS:C0205146
27753194	671	678	markers	T074	UMLS:C2745888
27753194	682	696	liver fibrosis	T038	UMLS:C0239946
27753194	742	748	method	T058	UMLS:C0871511
27753194	763	777	liver fibrosis	T038	UMLS:C0239946
27753194	837	851	fibrosis stage	T033	UMLS:C1954435
27753194	869	874	areas	T082	UMLS:C0205146
27753194	936	950	fibrosis stage	T033	UMLS:C1954435
27753194	1027	1053	aspartate aminotransferase	T103	UMLS:C0004002
27753194	1056	1080	alanine aminotransferase	T103	UMLS:C0001899
27753194	1088	1114	aspartate aminotransferase	T103	UMLS:C0004002
27753194	1118	1126	platelet	T017	UMLS:C0005821
27753194	1127	1138	ratio index	T170	UMLS:C0918012
27753194	1140	1156	fibrosis-4 index	T170	UMLS:C4304377
27753194	1162	1167	NAFLD	T038	UMLS:C0400966
27753194	1215	1229	fibrosis stage	T033	UMLS:C1954435
27753194	1396	1412	type IV collagen	T103	UMLS:C0009333
27753194	1470	1478	fibrosis	T038	UMLS:C0016059
27753194	1510	1534	alanine aminotransferase	T103	UMLS:C0001899
27753194	1550	1565	body mass index	T201	UMLS:C1305855
27753194	1586	1608	false positive results	T033	UMLS:C0205557
27753194	1628	1636	fibrosis	T038	UMLS:C0016059
27753194	1641	1646	NAFLD	T038	UMLS:C0400966
27753194	1657	1659	TE	T058	UMLS:C2748260
27753194	1704	1718	liver fibrosis	T038	UMLS:C0239946
27753194	1787	1789	TE	T058	UMLS:C2748260
27753194	1805	1825	liver fibrosis stage	T033	UMLS:C1954435
27753194	1844	1852	Japanese	T098	UMLS:C1556094
27753194	1853	1858	NAFLD	T038	UMLS:C0400966